Clinical Trial Update: A Study of KF-0210 in Advanced Solid Tumors Patients [Phase 1]

View source ↗

Summary

Phase 1 study of KF-0210 in advanced solid tumors has completed, evaluating safety and tolerability across multiple cancer indications. The trial included color…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Colorectal Cancer
• Gastric Cancer
• Lung Cancer
• Squamous Cell Carcinoma of the Esophagus

Drugs mentioned

• KF-0210

Snippet

Sponsor: Keythera Pharmaceuticals (Australia) Pty Ltd | Conditions: Advanced Solid Tumor, Colorectal Cancer | Phase 1 | Status: COMPLETED